Yonker ME, McVige J, Zeitlin L, Visser H, et al. A multicenter, randomized, double-blind, placebo-controlled, crossover trial to evaluate the efficacy and safety of zolmitriptan nasal spray for the acute treatment of migraine in patients aged 6 to 11 years, with an open-label extension. Headache 2022;62:1207-1217.
PMID: 36286602